chevron_leftBack
As of 20 June 2026, Kolon TissueGene, Inc. has a market cap of $5.9B USD, ranking #3322 globally and #1000 in the United States.
It ranks #246 in the Healthcare sector, and #54 in the Medical Devices industry.
Key Stats
Market Cap
$5.9BUSD
9.1T KRW
Enterprise Value
$6.03BUSD
9.1T KRW
Revenue (TTM)
$3.35MUSD
5.16B KRW
EBITDA (TTM)
-$14.27MUSD
-21.54B KRW
Net Income (TTM)
-$124.93MUSD
-192.59B KRW
PS Ratio
1764.1
PB Ratio
142.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Moon-jong Noh
open_in_new
Employees
29
Founded
1999
Website
tissuegene.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -5% | 7.9% | -15% | 10% | 136% | 156% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
950160
Kolon TissueGene Inc Korean Depository Receipts
ISIN: KR8840120008
Shares Out.:
Shares Outstanding:
84.736M1
Shares Float:
77.605M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
102,000 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Kolon TissueGene, Inc.
Kolon TissueGene, Inc. develops cell therapies for orthopedic diseases and other unmet medical needs. The company’s lead product is the TG-C that has completed Phase II trials to treat osteoarthritis, as well as rheumatoid arthritis, meniscus, and spinal discs. It is also developing cell therapies for musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
3K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
3K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
3K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
2K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
2K%
|
38.3
|
|
NYSE: BSX
|
$84.93B
1K%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
2K%
|
22.2
|
|
EPA: EL
|
$96.63B
2K%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$60.81B
930%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$45.08B
664%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$36.01B
510%
28.99B CHF
|
37.9
|
|
|
$30.14B
411%
203.66B CNY
|
26.0
|
chevron_leftBack